tiprankstipranks
Apyx Medical sees FY22 revenue $44M-$44.4M, consensus $45.2M
The Fly

Apyx Medical sees FY22 revenue $44M-$44.4M, consensus $45.2M

Goodwin continued: "In 2023, we expect to deliver growth in global sales of our Advanced Energy products of more than 35% year-over-year, fueled by strong execution on our commercial and regulatory objectives and improving generator demand trends as we move through fiscal 2023. We remain focused on maximizing our resources through prudent expense management and have recently implemented activities to eliminate certain operating expenses to improve cash flow, while preserving our capabilities as an organization. We also continue to actively evaluate all potential options to enhance our liquidity and financial condition."

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on APYX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles